CCM
SOPH icon

CAAS Capital Management’s SOPHiA GENETICS SOPH Stock Holding History

CAAS Capital Management’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-50,000
Closed -$877K – 1027
2021
Q3 		$877K Buy
+50,000
New +$879K 0.02% 525

Other funds holding SOPH

GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
GE
General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

CAAS Capital Management's SOPH Position: Q4 2021 in Review

CAAS Capital Management sold out of SOPHiA GENETICS (SOPH) in Q4 2021, closing a stake of 50,000 shares — an estimated $877K sold.

CAAS Capital Management first reported a position in SOPH in Q3 2021 and held it in 1 quarter. The position peaked at $877K in Q3 2021. 32 funds tracked by Wall St. Rank hold SOPH as of Q4 2021.

  • CAAS Capital Management reported no remaining SOPHiA GENETICS position as of Q4 2021 after selling out during the quarter.
  • CAAS Capital Management sold 50,000 SOPHiA GENETICS shares in Q4 2021, an estimated $877K.
  • CAAS Capital Management first reported a position in SOPHiA GENETICS in Q3 2021 and held it in 1 quarter.
  • CAAS Capital Management's SOPHiA GENETICS position peaked at $877K in Q3 2021.
  • 32 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q4 2021.

Based on CAAS Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.